Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
about
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trialStroke, dementia, and drug deliveryThe clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.Care of older people: Mental health problemsThe effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.The safety and tolerability of donepezil in patients with Alzheimer's disease.Pharmacological and Nonpharmacological Treatment for Apathy in Alzheimer Disease : A systematic review across modalitiesMemory clinics in context.Dementia caregiver intervention research: in search of clinical significanceDonepezil in Alzheimer's disease: From conventional trials to pharmacogeneticsPredicting the outcome of cholinesterase inhibitor treatment in Alzheimer's disease.Memory clinics.Donepezil: a review.Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementiaEarly identification and treatment of Alzheimer's disease: social and fiscal outcomes.Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.Memory enhancement: the progress and our fears.Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer's and neurodegenerative diseases.What factors influence mental health professionals when deciding whether or not to share a diagnosis of dementia with the person?Drugs for Alzheimer's disease.Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition.Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation.Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).Acetylcholinesterase treatment--modelling potential demand and auditing practice.
P2860
Q21245063-66902BFE-4724-4B6E-AAD8-C5DD1AAE0B0AQ28166505-95B07D0C-C8BA-4D36-AA52-B7E5837695DFQ30833736-4B2DD116-2C38-443C-A1F1-5E3810143AFCQ33804768-23DA2540-CF31-41E5-937A-E8230A5C16FFQ33869501-EA706354-C959-4BA6-BCAD-7AC253745A64Q34552035-5DB31D80-BCEF-4CA9-A5E7-383F862BC640Q34552380-209A55D5-8829-4B65-B174-AB01E3BC4F9BQ34571975-CDC21B55-3718-49E5-9316-BEC7F21C9514Q34915469-891FB1FC-AE5D-404A-909A-DFC733796DA0Q34965949-D1B15EB0-6D60-4EED-9010-84C7AAD2790CQ35486605-AC8FF441-644C-4A46-B697-7A55963EF57CQ36414294-2532E493-EB10-4B49-8ACD-B3CE1C047524Q36544994-5D251637-BD99-48DB-8F21-8DBBECE848F4Q36989228-75673287-517F-4829-90B9-477D4FE7E787Q37449105-3B662937-D2C6-4936-AEEA-E77807FF17E4Q37474101-12AF9C51-8E1F-4BD8-A6D0-1247AD880F96Q37691138-3F481128-7D24-4442-9DBE-F8945129BF47Q38519649-BB585851-9BF8-43CA-B64D-353F8A335EE5Q39418685-00B6BB72-35BB-45F5-90A4-4080895648E9Q42616104-4E2EF147-D97E-46E6-B4D8-FA12CC632AA4Q42773018-534100FE-6A16-44A9-9942-961461CA53B6Q44056102-A519B030-7DB1-437D-8030-5E12AE4F5C6CQ47417382-8E69012F-F6DA-41A4-8DEF-8D043FC89593Q48627531-3A7AF91F-A4AA-4E33-B95B-8E5649194516Q51961414-E09BE5A5-708C-4940-973C-BC0208926FED
P2860
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@en
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@nl
type
label
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@en
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@nl
prefLabel
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@en
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@nl
P2093
P2860
P1476
Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
@en
P2093
Matthews HP
Wilkinson DG
P2860
P304
P356
10.1002/1099-1166(200008)15:8<713::AID-GPS187>3.0.CO;2-I
P407
P577
2000-08-01T00:00:00Z